Both elevated seroreactivity to RBP3 and RLBP1 in AMD patients suggests that the inflammation, in particular, autoimmunity, is strongly associated with the pathogenesis of the disease [11]. The gene discussed is RLBP1; the disease is age-related macular degeneration.